Over 7,000 patients recruited to GHDR!
The Global Hip Dysplasia Registry (GHDR) has achieved another remarkable milestone, surpassing 7,000 patients recruited worldwide.
With collaborators from 32 sites across all 6 inhabited continents, the GHDR is advancing its mission to improve outcomes for children with hip dysplasia.
GHDR continues to be a leading collective force that aims to alleviate the burden of pediatric hip conditions such as hip dysplasia. This achievement further strengthens GHDR's position as a global leader in pediatric hip health, facilitating groundbreaking research that aims to reduce the burden of hip dysplasia and improve the lives of children worldwide.
Dr. Emily Schaeffer, Scientific Lead
“Reaching 7,000 patients in the GHDR demonstrates the incredible strength of our global collaboration and our dedication to improving care for children with hip dysplasia. With contributions from 32 centers worldwide, we are gathering an unprecedented amount of data that allows us to tackle pressing clinical questions. This milestone empowers us to explore more nuanced approaches to treatment and outcomes, pushing the boundaries of what we can achieve for children worldwide. It’s a powerful reminder of the impact of connecting local expertise on a global stage.”